1st Quarter - Report

W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 6074 (116th)

Health Issues HCR

Promoted life sciences community and communicated economic and health benefits of the industry.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Regulatory and legislative proposals in the Administrations Blueprint. H.R.3: Lower Drug Costs Now Act of 2019. H.R.19: Lower Costs, More Cures Act of 2019.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 19 (116th), H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.